IONTAS identifies novel SARS-CoV-2 neutralizing antibodies
Potent antibodies shown to retain binding to major COVID-19-causing “South African” variant
Potent antibodies shown to retain binding to major COVID-19-causing “South African” variant
The partnership will accelerate clinical validation and commercialization of certain NGS, mass spectrometry and immunology diagnostic tools
Innovative qPCR platform simplifies molecular diagnostic workflows for infectious disease, oncology and COVID-19 testing
The assay has the ability to sequence and surveil evolution of virus mutations over time and geography
This study offers new insights into high grade serous ovarian cancer that have the potential to make an impact in how patients are treated in the future
This partnership aims to offer an accelerated route to market rapid test technologies
Lenco Diagnostic Laboratories among first to offer Beckman Coulter’s semi-quantitative antibody test
Oxford-AstraZeneca coronavirus vaccine 79% effective against symptomatic COVID-19 overall
This week’s Reviewer in the Spotlight, Dr. Ritesh Bhole, discusses communication in science and the value of genuine product reviews, both positive and negative
The monthly safety report will be made public on the European Medicines Agency website
The findings come from the largest study to date to look at inflammatory markers in COVID-19
Panel designed to provide surveillance of ongoing mutations of virus that causes COVID-19
With this partnership, Repositive is expanding its personalized medicine capabilities to support more biopharma customers
The heart has a ‘natural backup pacemaker’ that can kick into action if the primary way the organ generates electrical signals fails
The test helps save on much-needed testing supplies since it allows for testing for all four viruses with one swab
Simple, powerful user experience combines with reliability and scalability allowing users to focus on experimental results instead of process
The partnership will pair Personalis’ NeXT tumor profiling with Natera’s Signatera™ for treatment monitoring
SARS-CoV-2 testing is a powerful tool for curbing the COVID-19 pandemic and safely reopening schools and businesses
The license from ERS expands ZeClinics CRISPR IP portfolio and increases the validity and potency of zebrafish models for the drug discovery process
The research brings a deeper understanding about how fructose could be linked to diabetes and obesity
International experts are joining forces to combat vaccine hesitancy by tackling its root cause
The Genedrive 96 SARS-CoV-2 kit is a simple, one-step RT-PCR test to detect SARS-CoV-2 RNA
Companion diagnostic can help guide treatment decisions in cases of NSCLC